Article Versions Notes

Prasse P, Iversen P, Lienhard M, Thedinga K, Herwig R, Scheffer T. Pre-Training on In Vitro and Fine-Tuning on Patient-Derived Data Improves Deep Neural Networks for Anti-Cancer Drug-Sensitivity Prediction. Cancers. 2022; 14(16):3950. https://doi.org/10.3390/cancers14163950

Prasse, Paul, Pascal Iversen, Matthias Lienhard, Kristina Thedinga, Ralf Herwig, and Tobias Scheffer. 2022. "Pre-Training on In Vitro and Fine-Tuning on Patient-Derived Data Improves Deep Neural Networks for Anti-Cancer Drug-Sensitivity Prediction" Cancers 14, no. 16: 3950. https://doi.org/10.3390/cancers14163950

Prasse, P., Iversen, P., Lienhard, M., Thedinga, K., Herwig, R., & Scheffer, T. (2022). Pre-Training on In Vitro and Fine-Tuning on Patient-Derived Data Improves Deep Neural Networks for Anti-Cancer Drug-Sensitivity Prediction. Cancers, 14(16), 3950. https://doi.org/10.3390/cancers14163950